Vivos Therapeutics, Inc. (VVOS) Total liabilities 2019–2025
Vivos Therapeutics, Inc. (VVOS) total liabilities at each fiscal year-end, per SEC filings.
$26.7MFY2025 · since FY2019: $9.2M → $26.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $26.7M | +264.3% |
| FY2024 | $7.3M | -29.0% |
| FY2023 | $10.3M | +15.7% |
| FY2022 | $8.9M | +9.4% |
| FY2021 | $8.2M | -3.1% |
| FY2020 | $8.4M | -8.4% |
| FY2019 | $9.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice